Watchlist Price Alert

Impel Pharmaceuticals Inc... (IMPL)

NASDAQ: IMPL · Real-Time Price · USD

0.04

-0.01 (-27.27%)

At close: Dec 20, 2023, 8:58 PM

Impel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	239K	15.16M	35.47M	60.65M	79.73M	97.83M	129.84M	88.21M	111.29M	60.95M	4.47M	7.09M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.83M	3.52M	3.93M	1.75M	187K	187K	187K	187K	n/a	187K	1.71M	187K
Receivables	6.59M	6.81M	6.28M	7.44M	6.13M	4.82M	3.89M	1.35M	1.27M	n/a	n/a	n/a
Inventory	6.86M	6.99M	8.01M	8.43M	8.62M	6.93M	5.5M	2.82M	1.55M	n/a	n/a	n/a
Other Current Assets	621K	418K	2.13M	3.28M	4.79M	4.88M	2.96M	2.19M	4.38M	4.62M	1.79M	1.08M
Total Current Assets	23.43M	32.9M	51.88M	79.81M	99.28M	114.43M	142.18M	94.58M	118.2M	65.57M	6.26M	8.17M
Property-Plant & Equipment	7.82M	8.39M	8.91M	7M	5.71M	5.82M	5.43M	3.15M	3.28M	3.41M	3.51M	3.7M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	11.65M	11.9M	12.85M	8.74M	5.9M	6M	5.62M	3.34M	3.28M	3.6M	5.22M	3.89M
Total Assets	35.07M	44.81M	64.73M	88.55M	105.17M	120.43M	147.8M	97.91M	121.48M	69.16M	11.48M	12.06M
Account Payables	3.73M	3.46M	6.13M	6.09M	4.75M	4.75M	8.99M	6.37M	8.7M	5.46M	6.42M	4.31M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.63M	3.17M
Short-Term Debt	112.56M	49.55M	1.74M	1.54M	1.35M	1.28M	999K	n/a	n/a	n/a	1.67M	417K
Other Current Liabilities	8.45M	68.21M	14.41M	14.53M	13.87M	12.27M	13.99M	9.59M	7.61M	3.55M	5.3M	2.62M
Total Current Liabilities	124.74M	121.22M	22.28M	22.16M	19.96M	18.3M	23.98M	15.95M	16.31M	9.01M	13.39M	10.53M
Long-Term Debt	2.23M	2.74M	51.17M	49.65M	48.95M	49M	48.7M	29.45M	29.29M	8.86M	15.33M	7.99M
Other Long-Term Liabilities	n/a	n/a	64.18M	60.9M	58.55M	49.23M	47.64M	n/a	n/a	n/a	127.17M	127.04M
Total Long-Term Liabilities	2.23M	2.74M	115.35M	110.54M	107.5M	98.23M	96.34M	29.45M	29.29M	8.86M	142.5M	135.03M
Total Liabilities	126.98M	123.97M	137.63M	132.71M	127.46M	116.52M	120.32M	45.4M	45.59M	17.86M	155.89M	145.56M
Total Debt	114.8M	52.3M	52.91M	51.19M	50.29M	50.27M	49.7M	29.45M	29.29M	8.86M	17M	8.41M
Common Stock	24K	24K	24K	24K	24K	23K	23K	23K	23K	19K	n/a	n/a
Retained Earnings	-372.35M	-358.53M	-351.18M	-321.11M	-298.07M	-266.97M	-241.77M	-214.8M	-190.06M	-165.03M	-149.55M	-138.26M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-120.56M	-69.16M	n/a	n/a
Shareholders Equity	-91.91M	-79.16M	-72.91M	-44.16M	-22.29M	3.91M	27.48M	52.51M	75.89M	51.3M	-144.41M	-133.5M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a